208 related articles for article (PubMed ID: 23857252)
1. MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC).
Petrelli A; Perra A; Cora D; Sulas P; Menegon S; Manca C; Migliore C; Kowalik MA; Ledda-Columbano GM; Giordano S; Columbano A
Hepatology; 2014 Jan; 59(1):228-41. PubMed ID: 23857252
[TBL] [Abstract][Full Text] [Related]
2. Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats.
Frau C; Loi R; Petrelli A; Perra A; Menegon S; Kowalik MA; Pinna S; Leoni VP; Fornari F; Gramantieri L; Ledda-Columbano GM; Giordano S; Columbano A
Hepatology; 2015 Jan; 61(1):249-59. PubMed ID: 25156012
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet.
Tryndyak VP; Ross SA; Beland FA; Pogribny IP
Mol Carcinog; 2009 Jun; 48(6):479-87. PubMed ID: 18942116
[TBL] [Abstract][Full Text] [Related]
4. YAP activation is an early event and a potential therapeutic target in liver cancer development.
Perra A; Kowalik MA; Ghiso E; Ledda-Columbano GM; Di Tommaso L; Angioni MM; Raschioni C; Testore E; Roncalli M; Giordano S; Columbano A
J Hepatol; 2014 Nov; 61(5):1088-96. PubMed ID: 25010260
[TBL] [Abstract][Full Text] [Related]
5. Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression.
Petrelli A; Perra A; Schernhuber K; Cargnelutti M; Salvi A; Migliore C; Ghiso E; Benetti A; Barlati S; Ledda-Columbano GM; Portolani N; De Petro G; Columbano A; Giordano S
Oncogene; 2012 Oct; 31(42):4517-26. PubMed ID: 22249248
[TBL] [Abstract][Full Text] [Related]
6. Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis.
Kowalik MA; Guzzo G; Morandi A; Perra A; Menegon S; Masgras I; Trevisan E; Angioni MM; Fornari F; Quagliata L; Ledda-Columbano GM; Gramantieri L; Terracciano L; Giordano S; Chiarugi P; Rasola A; Columbano A
Oncotarget; 2016 May; 7(22):32375-93. PubMed ID: 27070090
[TBL] [Abstract][Full Text] [Related]
7. Induction of autophagy promotes the growth of early preneoplastic rat liver nodules.
Kowalik MA; Perra A; Ledda-Columbano GM; Ippolito G; Piacentini M; Columbano A; Falasca L
Oncotarget; 2016 Feb; 7(5):5788-99. PubMed ID: 26735341
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages.
Sukata T; Sumida K; Kushida M; Ogata K; Miyata K; Yabushita S; Uwagawa S
Toxicol Lett; 2011 Jan; 200(1-2):46-52. PubMed ID: 21035526
[TBL] [Abstract][Full Text] [Related]
9. Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis.
Gao P; Wong CC; Tung EK; Lee JM; Wong CM; Ng IO
J Hepatol; 2011 Jun; 54(6):1177-84. PubMed ID: 21145831
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis.
Kowalik MA; Sulas P; Ledda-Columbano GM; Giordano S; Columbano A; Perra A
Oncotarget; 2015 Nov; 6(36):38749-63. PubMed ID: 26452031
[TBL] [Abstract][Full Text] [Related]
11. Androgen pathway stimulates microRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis.
Chen PJ; Yeh SH; Liu WH; Lin CC; Huang HC; Chen CL; Chen DS; Chen PJ
Hepatology; 2012 Aug; 56(2):632-43. PubMed ID: 22392644
[TBL] [Abstract][Full Text] [Related]
12. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.
Zhang Y; Takahashi S; Tasaka A; Yoshima T; Ochi H; Chayama K
J Gastroenterol Hepatol; 2013 Mar; 28(3):565-75. PubMed ID: 22989374
[TBL] [Abstract][Full Text] [Related]
13. Genetic inactivation of Nrf2 prevents clonal expansion of initiated cells in a nutritional model of rat hepatocarcinogenesis.
Orrù C; Szydlowska M; Taguchi K; Zavattari P; Perra A; Yamamoto M; Columbano A
J Hepatol; 2018 Sep; 69(3):635-643. PubMed ID: 29758334
[TBL] [Abstract][Full Text] [Related]
14. Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis.
Zavattari P; Perra A; Menegon S; Kowalik MA; Petrelli A; Angioni MM; Follenzi A; Quagliata L; Ledda-Columbano GM; Terracciano L; Giordano S; Columbano A
Hepatology; 2015 Sep; 62(3):851-62. PubMed ID: 25783764
[TBL] [Abstract][Full Text] [Related]
15. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
16. Role of Nrf2 and oxidative stress on fenofibrate-induced hepatocarcinogenesis in rats.
Nishimura J; Dewa Y; Okamura T; Jin M; Saegusa Y; Kawai M; Umemura T; Shibutani M; Mitsumori K
Toxicol Sci; 2008 Dec; 106(2):339-49. PubMed ID: 18775883
[TBL] [Abstract][Full Text] [Related]
17. Development of glutathione S-transferase-P-negative foci accompanying nuclear factor-erythroid 2-related factor 2 expression during early stage of rat hepatocarcinogenesis.
Fan Y; Shimizu T; Yamada T; Nanashima N; Akita M; Asano J; Tsuchida S
Cancer Sci; 2008 Mar; 99(3):497-501. PubMed ID: 18081878
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
[TBL] [Abstract][Full Text] [Related]
19. Transferrin and transferrin receptor gene expression and iron uptake in hepatocellular carcinoma in the rat.
Pascale RM; De Miglio MR; Muroni MR; Simile MM; Daino L; Seddaiu MA; Pusceddu S; Gaspa L; Calvisi D; Manenti G; Feo F
Hepatology; 1998 Feb; 27(2):452-61. PubMed ID: 9462644
[TBL] [Abstract][Full Text] [Related]
20. Activation of AKT pathway by Nrf2/PDGFA feedback loop contributes to HCC progression.
Liu D; Zhang Y; Wei Y; Liu G; Liu Y; Gao Q; Zou L; Zeng W; Zhang N
Oncotarget; 2016 Oct; 7(40):65389-65402. PubMed ID: 27588483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
